Form 4: Medtronic Director Randall J. Hogan Acquires Shares and Restricted Stock Units
SEC Form 4 Filing
Director Randall J. Hogan acquired 2,165 ordinary shares and was granted restricted stock units of Medtronic plc on April 29, 2024.
Summary
- On April 29, 2024, Randall J. Hogan, a director of Medtronic plc, acquired 2,165 ordinary shares at a price of $80.86 per share.
- This acquisition was in the form of restricted stock units that will vest on the one-year anniversary of the award date.
- Following the transaction, Hogan beneficially owns 45,280 ordinary shares, which includes 66 shares acquired through dividend reinvestment since the last report.
- The reporting person has signed the document through an attorney-in-fact, Thomas L. Osteraas, on May 1, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard transaction. Insider buying is generally viewed positively, but this is a routine filing.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The restricted stock units will vest on the one-year anniversary of the award date.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency to investors regarding the actions of company insiders.
Stakeholder Impact
- The acquisition of shares by a director may have a slightly positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 04/29/2024 | Date of transaction: Acquisition of ordinary shares and restricted stock units. |
| 05/01/2024 | Date of signature by attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.